Molecular epidemiology: a new tool in assessing risks of environmental carcinogens
1990; Wiley; Volume: 40; Issue: 5 Linguagem: Inglês
10.3322/canjclin.40.5.277
ISSN1542-4863
Autores Tópico(s)Carcinogens and Genotoxicity Assessment
ResumoCA: A Cancer Journal for CliniciansVolume 40, Issue 5 p. 277-288 ArticleFree Access Molecular epidemiology: A new tool in assessing risks of environmentalcarcinogens F. P. Perera DrPH, F. P. Perera DrPH Columbia University School of Public Health, New York, New YorkSearch for more papers by this author F. P. Perera DrPH, F. P. Perera DrPH Columbia University School of Public Health, New York, New YorkSearch for more papers by this author First published: September/October 1990 https://doi.org/10.3322/canjclin.40.5.277Citations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA 40: 9– 26, 1990. 2 Higginson J, Muir CS: The role of epidemiology in elucidating the importance of environmental factors in human cancer. Cancer Detect Prev 1: 79– 105, 1976. 3 IARC: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. Lyon, France, International Agency for Research on Cancer, Volumes 1–42 (suppl 7), 1987. 4 Huff JE, McConnell EE, Haseman JK: On the proportion of positive results in carcinogenicity studies in animals. Environ Mutagen 7: 427– 428, 1985. 5 Rosenkranz HS: Reply to Huff et al, 1985. Env Mut 7: 428, 1985. 6 OTA (Office of Technology Assessment): Identifying and Regulating Carcinogens. Washington, DC, Congress of the United States, 1987. 7 Doll R, Peto R: The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. New York, Oxford University Press, 1981. 8 Perera FP, Boffetta P, Nisbet ICT: What Are the Major Carcinogens in the Etiology of Human Cancer? in VT DeVita, S Hellman, SA Rosenberg (eds): Important Advances in Oncology. Philadelphia, JB Lippincott Company, 1989, pp 249– 265. 9 IARC: Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France, International Agency for Research on Cancer, Vol 138, 1986. 10 Cohen L: Diet and cancer. Sci Am 257: 42– 48, 1987. 11 Tuyns AJ: Alcohol, in D Schottenfeld, JF Fraumeni (eds): Cancer Epidemiology and Prevention. Philadelphia, WB Saunders, 1982, pp 293– 303. 12 Ames BN, Magaw R, Gold LS: Ranking possible carcinogenic hazards. Science 236: 271– 280, 1987. 13 Sugimura T, Sato S: Mutagens-carcinogens in foods. Cancer Res 43 (suppl): 2415S– 2421S, 1983. 14 Perera F, Boffetta P: Perspectives on comparing risks of environmental carcinogens. J Natl Cancer Inst 80: 1282– 1293, 1988 (Correction in J Natl Cancer Inst 81: 880, 1989). 15 Harris RH, Page T, Reiches NA: Carcinogenic hazards of organic chemicals in drinking water, in: HH Hiatt, JD Watson, JA Winsten (eds): Book A: Incidence of Cancer in Humans. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1977, pp 309– 330. 16 EPA: The Toxics Release Inventory: A National Perspective. Washington, DC, US Environmental Protection Agency, Office of Toxic Substances, Economics and Technology Division, June 1989. 17 NAS: Regulating Pesticides in Food: The Delaney Paradox. Washington, DC, National Academy of Sciences, National Research Council, National Academy Press, 1987. 18 Murphy RS, Kutz FW, Strassman SC: Selected pesticide residues or metabolites in blood and urine specimens from a general population survey. Environ Health Perspect 48: 81– 86, 1983. 19 EPA: A cancer risk-specific dose estimate for 2,3,7,8-TCDD (draft). Washington, DC, Environmental Protection Agency, 1987. 20 Nicholson WJ, Henneberger PK, Tarr D: Trends in cancer mortality among workers in the synthetic polymers industry. Prog Clin Biol Res 141: 65– 78, 1984. 21 Nicholson WJ, Perkel G, Selikoff IJ: Occupational exposure to asbestos: Population at risk and projected mortality, 1980–2030. Am J Ind Med 3: 259– 311, 1982. 22 Perera F, Schulte P, Santella RM, Brenner D: DNA adducts and other biomarkers in assessing the risk of complex mixtures, in: MD Waters, S Nesnow, J Llewtas, et al (eds): Genetic Toxicology of Complex Environmental Mixtures, VI. New York, Plenum Press, in press. 23 Perera FP: Molecular cancer epidemiology: A new tool in cancer prevention. J Natl Cancer Inst 78: 887– 898, 1987. 24 National Academy of Sciences, National Research Council, Committee on Biologic Markers: Biological markers in environmental health. Environmental Health Perspectives 64: 3– 9, 1987. 25 Hulka BS, Wilcosky T: Biological markers in epidemiologic research. Arch Env Health 43: 83– 89, 1988. 26 Schulte PA: A conceptual framework for the validation and use of biologic markers. Environmental Research 48: 129– 144, 1989. 27 Weinstein IB, Gattoni-Celli S, Kirschmeier P, et al: Multistage Carcinogenesis Involves Multiple Genes and Multiple Mechanisms: Cancer Cells 1: The Transformed Phenotype. New York, Cold Spring Harbor Laboratory, 1984, pp 229– 237. 28 Bartsch H, Hemminki K, O'Neill IK (eds): Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. Lyon, France, IARC Sci Publ No. 89, 1988. 29 Perera FP, Poirier MC, Yuspa SH, et al: A pilot project in molecular cancer epidemiology: Determination of benzo[a]pyrene-DNA adducts in animal and human tissues by immunoassay. Carcinogenesis 3: 1405– 1410, 1982. 30 Harris CC, Vahakangas K, Newman NJ, et al: Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 82: 6672– 6676, 1985. 31 Haugen A, Becher G, Benestad C, et al: Determination of polycyclic aromatic hydrocarbons in the urine, benzo[a]pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res 46: 4178– 4183, 1986. 32 Perera FP, Hemminki K, Young TL, et al: Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res 48: 2288– 2291, 1988. 33 Randerath K, Miller RH, Mittal D, Randerath E: Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: Application to unidentified genotoxicants. IARC: 361– 367, 1988. 34 Phillips DH, Hemminki K, Hewer A, Grover PL: Monitoring occupational exposure to carcinogens: Detection by 32P-postlabeling of aromatic DNA adducts in white blood cell DNA from foundry workers. Mut Res 204: 531– 541, 1988. 35 Everson RB, Randerath E, Santella RM, et al: Detection of smoking-related covalent DNA adducts in human placenta. Science 231: 54– 57, 1986. 36 Dunn BP, Stich HF: 32P postlabeling analysis of aromatic DNA adducts in human oral mucosal cells. Carcinogenesis 7: 1115– 1120, 1986. 37 Vahakangas K, et al: Synchronous fluorescence spectrophotometry of benzo[a]pyrene diolepoxide-DNA adducts in workers exposed to polycyclic aromatic hydrocarbons, in: Experimental and Epidemiologic Approaches to Cancer Risk Assessment of Complex Mixtures. Lyon, France, IARC, in press. 38 Weston A, Willey JC, Manchester DK, et al: Dosimeters of human carcinogen exposure: Polycyclic aromatic hydrocarbon macromolecular adducts. IARC 181– 189, 1988. 39 Neumann HG: Analysis of hemoglobin as a dose monitor for alkylating and arylating agents. Arch Toxicol 56: 1– 6, 1984. 40 Bryant MS, Skipper PL, Tannenbaum SR, Maclure M: Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 47: 602– 608, 1987. 41 Osterman-Golkar S, Bailey E, Farmer PB, et al: Monitoring exposure to propylene oxide through the determination of hemoglobin alkylation. Scand J Work Environ Health 10: 99– 102, 1984. 42 Tornqvist M, Osterman-Golkar S, Kautiainen A, et al: Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7: 1519– 1521, 1986. 43 Hoel DG, Kaplan NL, Anderson MW: Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science 219: 1032– 1037, 1983. 44 Vainio H, Waters MD, Norppa H: Mutagenicity of selected organic solvents. Scand J Work Environ Health II (suppl 1): 75– 82, 1985. 45 Evans HJ: Cytogenetic studies on industrial populations exposed to mutagens, in: BA Bridges, BE Butterworth, IB Weinstein (eds): Indicators of Genotoxic Exposure, Banbury Report #19. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1982. 46 Walles SAS, Norppa H, Osterman-Golkar S, Mäki-Paakkanen J: Single-strand breaks in DNA of peripheral lymphocytes of styrene-exposed workers. IARC 223– 226, 1988. 47 Hemstreet GP, Schulte PA, Ringen K, et al: DNA hyperploidy as a marker for biological response to bladder carcinogen exposure. Int J Cancer 42: 817– 820, 1988. 48 Slamon DJ, de Kernin JB, Verma IM, Cline MJ: Expression of cellular oncogenes in human malignancies. Science 224: 256– 262, 1984. 49 Spandidos DA, Kerr IB: Elevated expression of the human ras oncogene family in premalignant and malignant tumors of the colorectum. Br J Cancer 49: 681– 688, 1984. 50 Sukumar S, Pulciani S, Doniger J, et al: A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens. Science 223: 1197– 1199, 1984. 51 Jiang W, Kahn SM, Guillem JG, et al: Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer. Oncogene 4: 923– 928, 1989. 52 Brandt-Rauf PW: New markers for monitoring occupational cancer: The example of oncogene proteins. J Occup Med 30: 399– 404, 1988. 53 Stowers SJ, Maronpot RR, Reynolds SH, Anderson MW: The role of oncogenes in chemical carcinogenesis. Env Health Persp 75: 81– 86, 1987. 54 Gonzalez FJ, Jaiswal AK, Nebert DW: P-450 genes: Evolution, regulation and relationship to human cancer and pharmacogenetics. Cold Spring Harbor Symp Quant Biol 51 (pt 2): 879– 890, 1986. 55 Ayesh R, Idle JR, et al: Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312: 169– 170, 1984. 56 Cartwright RA, Glashan RW, Rogers HJ, et al: Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacokinetic epidemiological approach to bladder cancer. Lancet 2: 842– 845, 1982. 57 Carrano AV, Natarajan AT: Considerations for population monitoring using cytogenetic techniques. Mutation Res 204: 379– 406, 1988. 58 Francomano CA, Kazazian HH Jr: DNA analysis in genetic disorders. Ann Rev Med 37: 377– 395, 1986. 59 Rudiger HW, Nowak D, Hartmann K, Cerrutti P: Enhanced formation of benzo[a]pyrene: DNA adducts in monocytes of patients with a presumed predisposition to lung cancer. Cancer Res 45: 5890– 5894, 1985. 60 IARC: Polynuclear Aromatic Compounds, Part 3, Industrial Exposures in Aluminium Production, Coal Gasification. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France, International Agency for Research on Cancer, 1984. 61 Brandt-Rauf P, Smith S, Perera FP: Molecular Epidemiology and the Environmental Carcinogenesis of the Lung, in TJ Wick, EN Schacter (eds): Current Issues in Respiratory Public Health, vol 3, no. 1. Philadelphia, JB Lippincott Company, 1990, pp 44– 61. 62 Hemminki K, Twardowska-Saucha K, Scroczynski JW, et al: DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis, in press. Citing Literature Volume40, Issue5September/October 1990Pages 277-288 ReferencesRelatedInformation
Referência(s)